Biocryst Pharmaceuticals buy HC Wainwright

Summary

This prediction ended on 26.02.26 with a price of €6.30. The price of Biocryst Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.22%. HC_Wainwright has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. HC_Wainwright has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Biocryst Pharmaceuticals	-6.626%	-6.626%	-24.431%
iShares Core DAX®	-0,68 %	4,05 %	2,21 %
iShares Nasdaq 100	0,99 %	10,87 %	38,04 %
iShares Nikkei 225®	3,28 %	13,47 %	59,00 %
iShares S&P 500	0,62 %	6,20 %	26,15 %